Optimer Pharmaceuticals (OPTR +3.8%) trades up after BMC initiates the shares with a buy. The...

|About: Optimer Pharmaceuticals, Inc. (OPTR)|By:, SA News Editor

Optimer Pharmaceuticals (OPTR +3.8%) trades up after BMC initiates the shares with a buy. The firm says the company's newly launched antibiotic, Dificid, will exceed sales expectations in both the near and longer term.